Introduction
Gastric cancer is the second leading cause of cancer-related deaths worldwide. From the data provided by the International Agency for Research on Cancer, 1 malignancy of the stomach is the most common cancer in Asia, nearly two-thirds of which occurs in developing countries. 2 The World Health Organization and International Agency for Research on Cancer consensus group, 3 stated in 1994 that there was sufficient epidemiologic and histologic, 4, 5 evidence to classify Helicobacter pylori as a definite carcinogen. Our understanding of gastric cancer underwent a discernible shift with the discovery of H. pylori. Infection with H. pylori probably still plays a leading role in the development of gastric cancer. 6 In a country such as India, where >75% of the population are infected, it has been proved beyond doubt that H. pylori infection is high, especially in areas of low socioeconomic status and bad hygiene conditions. 7 The vast majority of H. pylori infected people remain asymptomatic throughout their lives with no major clinical events, and only a small proportion present with some form of gastric disorder, such as gastric carcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. 8 A study by Konturek et al. 9 showed that the risk of gastric cancer in patients with H. pylori markedly increased with infection with bacteria that were cytotoxin-associated gene (CagA + ) in the age group 40-49 years. Further, a similar study from the Indian sub-continent reported a higher risk of developing gastric cancer in younger patients infected with H. pylori. 10 Although some studies have rejected a direct link between H. pylori infection and gastric cancer, 10, 11 several prospective studies have supported a positive association between these two entities. 12, 13 Perhaps the most convincing evidence for the association between H. pylori infection and gastric carcinoma was provided by a Japanese study, 14 which showed development of gastric cancer in 2.9% of H. pylori infected people, whereas no uninfected subjects developed it. In addition, a number of environmental factors have been shown to be associated with gastric cancer, including high salt diets, N-nitrosamines and low intake of dietary antioxidants typically found in fresh fruit and vegetables. 15, 16 A large number of studies have shown increased risk of gastric cancer in people with CagA + H. pylori. However, other data have revealed that the occurrence of gastric malignancy is independent of CagA status. 17 In our country, one small study and several studies from India failed to show higher frequency of CagA + H. pylori infection in patients with gastric cancer than controls. Available evidences did not support difference in H. pylori strains as an explanation for this enigma. Despite established etiological role of H. pylori, situation is somewhat enigmatic in Asian countries because in countries with higher frequency of infection, there is lower rate of gastric cancer. Host's genetic make-up and dietary and environmental factors might explain this enigma. 18 Several case-control studies, in different countries, have investigated the association between CagA + H. pylori and gastric cancer, and most evidence in literature agrees this association does exist. 19, 20 Despite H. pylori being an important agent for causing gastric cancer, a randomized controlled trial from high risk region. 21 On the other hand, several studies from India also failed to show higher frequency of H. pylori infection in patients with gastric cancer than controls. 18 The conflicting results had not been highlighted firmly as very few studies were carried out till to date. In our country, study had been carried out showing relation of H. pylori with gastric malignancy.
| Original | Article |

Abstract
The aim of this study was to find out the association of the CagA + Helicobacter pylori infection and gastric carcinoma. This cross sectional comparative study was conducted on 40 patients of gastric carcinoma and 40 healthy volunteers from January 2011 to December 2012. Then, Cag A status was ascertained in both the groups by ELISA method. There was no significant difference between the case and control in relation to Cag A status. A total of 40 cases with carcinoma stomach and another 40 patients with apparently normal stomach regarded as control were selected during the study period according to inclusion and exclusion criteria
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Results Figure 1 shows the distribution of site of involvement in gastric carcinoma. Antrum and pylorus were involved in 15 (37.5%) cases; body and antrum were involved in 10 (25.0%) cases; body and fundus were involved in 6 (15.0%) cases; body was involved in 4 (10.0%) cases; fundus was involved in 2 (5.0%) cases; and antrum, body and fundus were involved in 4 (10.0%) cases of the gastric carcinoma. Table I shows all the study subjects are H. pylori positive in serogical test using ELISA. 30 showed that antibodies to CagA protein are not predictive of serious gastroduodenal disease. Ghoshal et al. 31 supported this result that frequency of CagA IgG antibody was similar among the patients with gastric carcinoma and the controls, suggesting that difference in virulence factors of H. pylori, at least CagA is unlikely to explain the variation in outcome of H. pylori infection. The current study result was also correlated with the study of Hassan et al. 22 
Conclusion
No significant association of CagA + H. pylori strain and risk of gastric carcinoma was found in the present study. There are several factors other than Cag A positivity in H. pylori infection in the causation of gastric carcinoma. 
